LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 2,370 pages found matching General Motors- Suicide Risk of Neurontin Kept Hidden for Years
Feb-27-07 Washington, DC: Neurontin , the all-time poster child for an illegally promoted off-label drug, was marketed by Warner-Lambert and its Parke-Davis division until Pfizer acquired the company in 2000. The term "off-label" means prescribing a drug for indications not listed on the label, upping the recommended dose, prescribing a drug in combination with... - Did SSRI Meds cause my Son's Birth Defects?
Feb-26-07 Salt Lake City, UT Trudy Hanson is sitting in a waiting room at Primary Children's Hospital, a room that has become her second home since giving birth to her son - this is Michael's 14th surgery. Trudy says she can't help but blame herself for taking Effexor while she was pregnant. "I started taking Effexor a few months before I was pregnant and cont... - Off-Label Depakote Sales Stronger Than Ever
Feb-11-07 Washington, DC: The epilepsy drug, Depakote , earned Abbott Laboratories $384 million in the 4th quarter of 2006, and overall sales rose 18.5% to $1.2 billion last year. The rising sales are a result of Depakote (valproate) being increasingly prescribed for conditions other than epilepsy like mood disorders, manic depression and migraines. Doctors are... - Consequences of Rampant Off-Label Prescribing of Depakote
Feb-7-07 Washington, DC: The antiepileptic drug, Depakote , is one of the most heavily prescribed medications for off-label use. The Epilepsy Foundation reports that there are an estimated 1 million women in the US with epilepsy, but the number of women being treated with antiepileptics is two to three times higher than the number of women with the disorder. Ex... - TJX Customer Information Stolen in Security Breach
Feb-6-07 Boston, MA TJX Cos. is in hot water after a class action lawsuit was filed January 29th in response to a security breach at the company. The lawsuit alleges that TJX did not properly secure customer credit and debit card information and accuses the company of not alerting customers to the security breach for a month. The suit seeks compensation for d... - Higher Standards for Ortho Evra?
Feb-5-07 Philadelphia, PA The FDA has recently considered setting higher standards for new birth control drugs before they are approved for market. Some pills seem to be less effective at preventing pregnancy because manufacturers have started using lower doses of hormones that stop ovulation, while the Ortho Evra patch has seen the reverse: higher doses of ho... - FedEx Law Suit: Couriers Sign Up
Feb-2-07 Yorbalinda, CA Debbie Johnson worked as a courier at FedEx for more than 20 years. She loved her job, but recently she has come to dread going to work. "FedEx was based on the PSP philosophy - people, service, profit," she said, "But now it's spelled backwards." "The company started changing in the early 90s and most of us couriers were forced to do u... - Depakote Warning: Do Not Get Pregnant
Feb-1-07 Lexington, NC Back in 1981, Sonja Ashby was prescribed Depakane, similar to Depakote , for epilepsy. Sonja and her husband wanted children but they were warned by her doctor that it could cause severe birth defects so they decided it wasn't worth the risk. Then Depakote came on the market. Fast forward to 1985: "My husband read an article about a docto... - GlaxoSmithKline Defamed With Truth About Paxil
Jan-31-07 London, UK: GlaxoSmithKline has labeled the allegations made in a Panorama television program that said the company had suppressed the results of clinical trials that showed Paxil was ineffective and caused children to become suicidal "defamatory." According to the January 30, 2007, Guardian, an official at the company said Glaxo had looked into takin... - No End in Sight for Fen-Phen Lawsuits
Jan-29-07 Rutherford, NJ: On December 5, 2006, five women with ages ranging from 53 to 71, who took the appetite suppressants drugs known as fen-phen in 1996 and 1997, filed lawsuits against Wyeth Pharmaceuticals after being diagnosed with a life-threatening lung disorder. These lawsuits demonstrate that the harm caused by fen-phen can surface many years after a... - Lilly's Legal Battle over Zyprexa Documents Continues
Jan-8-07 On January 3, 2007, a hearing was held before Judge Jack Weinstein, in a US District Court in New York, on a motion by Eli Lilly to extend an injunction to conceal company documents that show Lilly hid the lethal side effects of Zyprexa for a decade and engaged in an illegal off-label marketing scheme to promote the drug for unapproved uses. Zyprexa... - Novartis failed to Warn about Elidel Cancer Link
Dec-28-06 Washington, DC: Most lawsuits in which drug makers have tried to use preemption to dismiss failure-to-warn claims have been against companies accused of failing to warn about the risk of suicide associated with antidepressants known as selective serotonin inhibitors or SSRIs. However, a case in Pennsylvania against Novartis, involves a toddler who devel... - DSM Billing Bible - Big Pharma Best Seller
Dec-27-06 Washington, DC One-hundred percent of the experts involved in writing diagnostic criteria for mood disorders and schizophrenia for the, "Diagnostic and Statistical Manual for Mental Disorders (DSM)," have undisclosed financial ties to the pharmaceutical companies whose drugs are used to treat those conditions. The April 2006 study in the journal, Psycho... - Spine Surgery performed much too Often
Dec-23-06 New Jersey: For senior citizens, the chances of receiving spine surgery, along with the serious complications that often follow, depends on where a patient lives, according to researchers from Dartmouth Medical School in the November 2006 medical journal Spine. For the study, the researchers analyzed data on lower back (lumbar) surgery among Medicare re... - Doctor's Perks and Free Drug Samples Cost Patients Plenty
Dec-20-06 Washington, DC: In the debate over whether Big Pharma's perks lead doctors to prescribe high priced brand-name drugs over equally effective generics, the question to ask is whether an industry would direct 90% of a $20 billion marketing budget at doctors if it did not work. As lawmakers enact measures to limit the drug company's influence over the medic... - Panacryl Sutures: Recent lawsuits just Tip of the Iceberg
Dec-19-06 Princeton, NJ In September 2002, a lawyer had a visit from a woman who told him a medical story that he initially thought was a medical malpractice situation. She had undergone several surgeries including colon-rectal surgery and a colostomy reversal and every time she was sewn up and sent home, her condition deteriorated. He got her medical records and... - Zyprexa Cat Out Of The Bag
Dec-19-06 Washington DC Documents acquired by the New York Times from attorney Jim Gottstein show that Eli Lilly ran a "Viva Zyprexa" marketing campaign to convince doctors to prescribe Zyprexa off-label and between 1999 and 2002, its sales doubled from $1.5 billion to $3 billion. Although most people would recognize that the Zyprexa cat cannot be stuffed ba... - Flu Vaccines - Open Season
Dec-15-06 For all the frantic, unvaccinated citizens fearing the "upcoming" peak of flu season—rest assured, coming down with a flu infection is the least of your worries. Despite the governments statements urging individuals to vaccinate their children, the threat of an infantile influenza fatality is just about as serious as the dreaded hangnail. Noneth... - It's Just Lunch - Not honoring contracts
Dec-11-06 Chicago, IL: It's Just Lunch is a dating service that claims to offer specialized match-making services for its professional clientele. However, many former clients and employees argue that It's Just Lunch is less than professional and fails to honor its contractual obligations. Over the past few months, many complaints about It's Just Lunch have be... - Glaxo Writing Checks Left and Right to Settle Paxil Legal Battles
Dec-3-06 Madison County, IL: GlaxoSmithKline is no doubt looking forward to the New Year because the end of this one is becoming costlier by the month. On November 1, 2006, the Associated Press reported that Glaxo had agreed to pay $63.8 million to settle a class action lawsuit with allegations that Glaxo promoted Paxil for use with children and adolescents wh...